Patent ID: 6525035
Filing Date: 2003-02-25
Classification: A61K

Abstract:
A pharmaceutical composition comprising a pharmaceutically acceptable carrier, and a therapeutically effective amount of a combination of 1) isolated polyprenol monophosphates of the formula Hâ€”[â€”CH2â€”C(CH3)&boxH;CHâ€”CH2]n-Oâ€”P(&boxH;O)(OH)2 wherein n is an integer from 6-19 inclusive, or a salt thereof, and 2) isolated polyprenol pyrophosphates of the formula Hâ€”[â€”CH2â€”C(CH3)&boxH;CHâ€”CH2]mâ€”Oâ€”P(&boxH;O)(OH)â€”Oâ€”P(&boxH;O)(OH)2 wherein m is an integer from 6-19 inclusive, or a salt thereof.